Sunday, July 02, 2017 4:34:54 PM
If you look at historical quarters, the second quarter is the highest in sale even before the FDA recently cleared the product for OVER THE COUNTER sale in the USA. Remember that Biel added recently the TESCO sale in the UK but toward the end of the quarter, and also updated their product line in the USA to comply with FDA requirements.
Q2/2016 was unique because of the major article published in the UK about the Actipatch on April 23, 2016.
http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html
It will be great if Q2/2017 beats or matches the figures below. With more stores OTC access, especially in the USA, the best quarter expected for this year is Q4/2017. Biel needs something on the order of 1.2 million in quarterly sale to breakeven. It is definitely achievable before or by the end of the year. Dewmboom predicts profits in Q4/2017 for the quarter. Also Dewmboom predicts that Biel will become profitable starting with Q1/2018. That is why I am forcasting an early retirement in late 2018.
Invest in Biel and don't trade it!!!!!
Sale:
Q2/2015: $ 675,348
Q2/2016: $ 689,659
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM